Shandong Lukang Pharmaceutical (SHA:600789) will invest 193.5 million yuan to build a continuous intelligent manufacturing chemical active pharmaceutical ingredient (API) project at its biomedical industrial park.
The 18-month project will include a multi-purpose API workshop, storage facilities and supporting control infrastructure, according to a Thursday filing with the Shanghai bourse.